As of 2025-12-17, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (28.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -174.1%.
The range of the Relative Valuation is (22.87) - (30.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 18.7x | 17.1x |
| Forward P/E multiples | 13.9x - 21.1x | 17.4x |
| Fair Price | (22.87) - (30.72) | (28.34) |
| Upside | -159.8% - -180.4% | -174.1% |
| Date | P/E |